This Notice of Special Interest (NOSI) seeks to expand the breadth of scientific research on the clinical course, prevention and treatment of diseases within the mission of the National Heart, Lung, and Blood Institute (NHLBI) by leveraging ongoing clinical research studies through ancillary studies. The purpose of this NOSI is to invite research project applications to conduct focused ancillary studies to large ongoing clinical trials (including late-stage T4 implementation clinical trials), observational studies, and registries. This NOSI also serves as a replacement for NOT-HL-20-755 (expired as of November 6, 2021).
NHLBI supports a large number of multi-center clinical trials, observational studies, and implementation trials. Each of these studies represents a substantial financial commitment by the NHLBI to establish infrastructure for participant recruitment and evaluation. These unique resources can be leveraged by supporting additional studies to collect new information beyond what has been proposed under the parent study. Additionally, studies not sponsored by NHLBI, including those not originally designed to address a disease within the mission of NHLBI, may yield important insights and additional information of interest to the Institute through ancillary studies.
NOT-HL-21-030
Expiration Date: New Date May 08, 2025 (Original Date: May 08, 2023) per issuance of NOT-HL-23-071
Sponsor Institute/Organizations: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Oct 05, 2024
Varies
Affiliation: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.